Partners News Cell4Pharma enters into distribution agreement and strategic partnership with MatTek
25 March 2022

MatTek Life Sciences, a Boston-area tissue engineering company and a member of the BICO Group, announced today it has entered into a distribution agreement and strategic partnership with Radboudumc’s spin-off company Cell4Pharma, a company specializing in commercially available human renal cells, to distribute its products in the US as well as develop a new in vitro kidney model. “The strategic partnership with MatTek is in line with our goal to accelerate our growing global network of strategic partners. This partnership supports our mission to support human-relevant research by providing synergistic life science products and services,” said Ron Byron, CEO of Cell4Pharma. Read full article here: MatTek Enters Distribution Agreement and Strategic Partnership with Cell4Pharma (bico.com)

Related news items


Meet BabyChecker!

24 September 2021

On September 20th, 2021, Delft Imaging launched BabyChecker: an affordable and portable smartphone-based ultrasound solution.

read more

ScreenPoint Medical raises $28 million for further development Series C funding led by Insight Partners

2 August 2021

ScreenPoint Medical has raised $28 million in a Series C financing. ScreenPoint Medical is a spin-off of the Radboudumc.

read more

New ultra-high field MRI system available for Radboudumc and Radboud University

10 June 2021

Recently, the Hahn institute in Essen has received a new heart: a 20-ton ultra-high-field MRI scanner from Siemens Healthcare with a magnetic field strength of 7 Tesla. The new CE-approved scanner is ready for business, and projects on body and brain imaging are starting up.

read more

Strategic partnership Enzyre BV and Takeda for better diagnostics for bleeding disorders

16 April 2021

Takeda announced to have entered into a strategic partnership with Enzyre BV, a Radboudumc spin-off company.

read more